MAG and early-onset autosomal dominant Alzheimer disease: Indeed, in cases with no or minimal Alzheimer’s disease pathology (BS0–II), MAG:PLP1 declined and VEGF and fibrinogen increased by magnitudes similar to those in end-stage Alzheimer’s disease in control donors with terminal infection.